HYDROmorphone HCI 0 recalled over sterility concerns
- Recall date
- April 20, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Pharmakon Pharmaceuticals, Inc. recalls HYDROmorphone HCI 0.4mg/ml in 0.9% Sodium Chloride, 30 mL PCA Vial, Rx Only, Compounded by PHARMAKON Pharmaceuticals, N…
- Recall number
- D-1304-2016
- FDA classification
- Class II
- Brand / firm
- Pharmakon Pharmaceuticals, Inc.
- Sold / distributed
- Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
HYDROmorphone HCI 0.4mg/ml in 0.9% Sodium Chloride, 30 mL PCA Vial, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0813-68
Get recall alerts
Free email alert whenever Pharmakon Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pharmakon Pharmaceuticals, Inc.